Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays revision number v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T12:46:49.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no other changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:28:52.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.4.0 to v3.4.1 (added v3.4.1 and removed v3.4.0).
    Difference
    0.1%
    Check dated 2026-02-06T10:43:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI updates include adding Show glossary and Hide glossary controls, and introducing new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' in Study Record Dates, while removing older labels like 'Last Update Submitted that met QC Criteria' and 'Last Update Posted (Estimated)'. Footer/meta updates include adding 'No FEAR Act Data' and 'Revision: v3.4.0', while removing 'No FEAR Act data' and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T18:07:26.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 at the bottom of the page.
    Difference
    0.0%
    Check dated 2026-01-15T10:53:10.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Study status updated to Completed with an actual completion date of 2025-10-27, replacing the previous Active, not recruiting status. A list of trial locations across multiple US sites was added.
    Difference
    2%
    Check dated 2025-12-17T19:58:15.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.